Impact of Bacillus Clausii Administration on Irritable Bowel Syndrome Patients
NCT03359499
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Irritable Bowel Syndrome
Interventions
DRUG:
Bacillus clausii
DRUG:
Trimebutine
Sponsor
Hospital Britanico